Title | Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Béguelin W, Teater M, Meydan C, Hoehn KB, Phillip JM, Soshnev AA, Venturutti L, Rivas MA, Calvo-Fernández MT, Gutierrez J, Camarillo JM, Takata K, Tarte K, Kelleher NL, Steidl C, Mason CE, Elemento O, C Allis D, Kleinstein SH, Melnick AM |
Journal | Cancer Cell |
Volume | 37 |
Issue | 5 |
Pagination | 655-673.e11 |
Date Published | 2020 May 11 |
ISSN | 1878-3686 |
Abstract | Follicular lymphomas (FLs) are slow-growing, indolent tumors containing extensive follicular dendritic cell (FDC) networks and recurrent EZH2 gain-of-function mutations. Paradoxically, FLs originate from highly proliferative germinal center (GC) B cells with proliferation strictly dependent on interactions with T follicular helper cells. Herein, we show that EZH2 mutations initiate FL by attenuating GC B cell requirement for T cell help and driving slow expansion of GC centrocytes that become enmeshed with and dependent on FDCs. By impairing T cell help, mutant EZH2 prevents induction of proliferative MYC programs. Thus, EZH2 mutation fosters malignant transformation by epigenetically reprograming B cells to form an aberrant immunological niche that reflects characteristic features of human FLs, explaining how indolent tumors arise from GC B cells. |
DOI | 10.1016/j.ccell.2020.04.004 |
Alternate Journal | Cancer Cell |
PubMed ID | 32396861 |
PubMed Central ID | PMC7298875 |
Grant List | R01 CA198089 / CA / NCI NIH HHS / United States R35 CA220499 / CA / NCI NIH HHS / United States P41 GM108569 / GM / NIGMS NIH HHS / United States R01 AI104739 / AI / NIAID NIH HHS / United States P30 CA060553 / CA / NCI NIH HHS / United States |